Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Treating impaired cognition in schizophrenia: the case for combining cognitive-enhancing drugs with cognitive remediation.

Michalopoulou PG, Lewis SW, Wykes T, Jaeger J, Kapur S.

Eur Neuropsychopharmacol. 2013 Aug;23(8):790-8. doi: 10.1016/j.euroneuro.2013.03.012. Epub 2013 Apr 22. Review.

PMID:
23619163
2.

[Learning potential and cognitive remediation in schizophrenia].

Raffard S, Gely-Nargeot MC, Capdevielle D, Bayard S, Boulenger JP.

Encephale. 2009 Sep;35(4):353-60. doi: 10.1016/j.encep.2008.06.014. Epub 2009 Jan 8. Review. French.

PMID:
19748372
3.

Integrating psychopharmacology and cognitive remediation to treat cognitive dysfunction in the psychotic disorders.

Medalia A, Opler LA, Saperstein AM.

CNS Spectr. 2014 Apr;19(2):115-20. doi: 10.1017/S1092852913000461. Epub 2013 Jul 23. Review.

PMID:
23880228
4.

Assessing and treating cognitive impairment in schizophrenia: current and future.

Lin CY, Tsai GE, Lane HY.

Curr Pharm Des. 2014;20(32):5127-38. Review.

PMID:
24410565
5.

Cognitive remediation for schizophrenia: it is even more complicated.

Wykes T, Huddy V.

Curr Opin Psychiatry. 2009 Mar;22(2):161-7. doi: 10.1097/YCO.0b013e328322fbf4. Review.

PMID:
19553870
6.

[The cognitive paradigm in the rehabilitation of schizophrenia - focusing on cognitive remediation].

Muth V, Gyüre T, Váradi E.

Neuropsychopharmacol Hung. 2015 Sep;17(3):129-40. Review. Hungarian.

7.

[First-episode psychosis, cognitive difficulties and remediation].

Vidailhet P.

Encephale. 2013 Sep;39 Suppl 2:S83-92. doi: 10.1016/S0013-7006(13)70101-5. Review. French.

PMID:
24084427
8.

Treating cognitive dysfunction in patients with schizophrenia.

Galletly CA, Clark CR, MacFarlane AC.

J Psychiatry Neurosci. 2000 Mar;25(2):117-24. Review.

9.

[Cognitive remediation and work outcome in schizophrenia].

Franck N.

Encephale. 2014 Jun;40 Suppl 2:S75-80. doi: 10.1016/j.encep.2014.04.004. Epub 2014 Jun 13. Review. French.

PMID:
24930723
10.

Does cognitive remediation for schizophrenia improve functional outcomes?

Medalia A, Saperstein AM.

Curr Opin Psychiatry. 2013 Mar;26(2):151-7. doi: 10.1097/YCO.0b013e32835dcbd4. Review.

PMID:
23318663
11.

[Cognitive rehabilitation for people living with schizophrenia - the newest interventions].

Linke M, Jarema M.

Psychiatr Pol. 2014 Nov-Dec;48(6):1179-88. doi: 10.12740/PP/21931. Review. Polish.

12.

Approaches to cognitive remediation of neuropsychological deficits in schizophrenia: a review and meta-analysis.

Kurtz MM, Moberg PJ, Gur RC, Gur RE.

Neuropsychol Rev. 2001 Dec;11(4):197-210. Review.

PMID:
11883669
13.

Cognitive rehabilitation for schizophrenia and the putative role of motivation and expectancies.

Velligan DI, Kern RS, Gold JM.

Schizophr Bull. 2006 Jul;32(3):474-85. Epub 2006 Apr 26. Review.

14.

Developing drugs for cognitive impairment in schizophrenia.

Breier A.

Schizophr Bull. 2005 Oct;31(4):816-22. Epub 2005 Sep 8. Review.

PMID:
16150959
15.

[What perspectives for cognitive remediation in schizophrenia?].

Correard N, Mazzola-Pomietto P, Elissalde SN, Viglianese-Salmon N, Fakra E, Azorin JM.

Encephale. 2011 Dec;37 Suppl 2:S155-60. doi: 10.1016/S0013-7006(11)70044-6. Review. French.

PMID:
22212847
16.

[Outcome studies of cognitive remediation for schizophrenia].

Mogami T, Ikezawa S, Kaneko K, Pu S, Nakagome K.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2011 Nov;31(5-6):245-9. Review. Japanese.

PMID:
22256614
17.

Cognitive enhancing agents in schizophrenia and bipolar disorder.

Vreeker A, van Bergen AH, Kahn RS.

Eur Neuropsychopharmacol. 2015 Jul;25(7):969-1002. doi: 10.1016/j.euroneuro.2015.04.014. Epub 2015 Apr 18. Review.

PMID:
25957798
18.

[Treatment of cognitive deficits in schizophrenia. Part 2: Pharmacological strategies].

Roesch-Ely D, Pfueller U, Mundt C, Müller U, Weisbrod M.

Nervenarzt. 2010 May;81(5):564-76. doi: 10.1007/s00115-009-2919-6. Review. German.

PMID:
20195567
19.

Impact on cognition of the use of antipsychotics.

Sharma T.

Curr Med Res Opin. 2002;18 Suppl 3:s13-7. Review.

PMID:
12418607
20.

Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics.

Sumiyoshi T, Bubenikova-Valesova V, Horacek J, Bert B.

Adv Ther. 2008 Oct;25(10):1037-56. doi: 10.1007/s12325-008-0102-2. Review.

PMID:
18839076

Supplemental Content

Support Center